News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Endosense Builds Further Validation for the TactiCath(R) with a Host of New Clinical Abstracts


6/17/2010 8:18:20 AM

GENEVA--(BUSINESS WIRE)--Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced the unveiling of five new clinical abstracts on the use of contact force sensing in catheter ablation at Cardiostim 2010, June 16 – 19 in Nice, France. The abstracts, which feature the company’s TactiCath force-sensing ablation catheter, build on a growing body of research demonstrating the potential of contact force sensing to improve the safety and effectiveness of catheter ablation procedures.

Read at BioSpace.com

comments powered by Disqus
Endosense
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES